Medicare Enrolled
Dr. William Lumry, M.D.
Optician · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lumry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lumry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lumry
Dr. William Lumry is an optician specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lumry performed 35,130 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lumry received a total of $1,340,333 from 42 pharmaceutical and/or device companies across 1617 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lumry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in TX
$1,340,333 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,130
Medicare services
Top 2% in TX for optician
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
8,946 | $11 | $15 |
| Omalizumab injection (Xolair) for asthma/allergy | 7,230 | $30 | $39 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
7,034 | $34 | $43 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
3,780 | $3 | $4 |
| Allergen injection administration Professional service for the administration of a single allergen injection. |
2,376 | $7 | $10 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
2,232 | $8 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,046 | $62 | $89 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
602 | $16 | $23 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
458 | $56 | $135 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
358 | $6 | $8 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
302 | $49 | $74 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
229 | $91 | $127 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
149 | $30 | $31 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
146 | $72 | $73 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
69 | $29 | $39 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
47 | $8 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
43 | $73 | $113 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $110 | $167 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $38 | $57 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
14 | $34 | $47 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
13 | $37 | $61 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $23 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.6% high complexity
35.0% medium
42.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,340,333
Total received (2018-2024)
Avg $191,476/year across 7 years
Top 0% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,617
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$241,895
2023
$219,929
2022
$197,482
2021
$137,516
2020
$68,707
2019
$253,902
2018
$220,901
Payments by company (2024)
BioCryst US Sales Co., LLC
$62,597
CSL Behring
$59,557
Takeda Pharmaceuticals U.S.A., Inc.
$46,902
AstraZeneca Pharmaceuticals LP
$25,582
Pharming Healthcare, Inc.
$14,672
GlaxoSmithKline, LLC.
$14,357
Consortium of Independent Immunology Clinics, LLC
$10,441
BioCryst Pharmaceuticals, Inc.
$6,288
Eli Lilly and Company
$800
Genentech USA, Inc.
$293
Grifols USA, LLC
$156
Regeneron Healthcare Solutions, Inc.
$101
PFIZER INC.
$99
HOSPIRA, INC.
$26
Octapharma USA, Inc.
$23
Top 3 companies account for 69.9% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$268,001
CSL Behring
$249,421
Takeda Pharmaceuticals U.S.A., Inc.
$188,338
BioCryst US Sales Co., LLC
$144,562
AstraZeneca Pharmaceuticals LP
$104,868
GlaxoSmithKline, LLC.
$103,219
Pharming Healthcare, Inc.
$75,174
Regeneron Healthcare Solutions, Inc.
$44,536
BioCryst Pharmaceuticals, Inc.
$37,091
Genentech USA, Inc.
$36,388
Grifols USA, LLC
$16,776
OptiNose US, Inc.
$12,684
Kedrion S.p.A.
$12,014
Consortium of Independent Immunology Clinics, LLC
$10,441
Optinose US, Inc.
$9,383
GENZYME CORPORATION
$5,924
Fresenius Kabi USA, LLC
$5,674
NOVARTIS PHARMACEUTICALS CORPORATION
$5,615
Greer Laboratories, Inc.
$2,000
Amgen Inc.
$1,759
Allergan Inc.
$1,733
Eli Lilly and Company
$800
TerSera Therapeutics LLC
$612
Alnylam Pharmaceuticals Inc.
$568
Vertex Pharmaceuticals Incorporated
$525
PFIZER INC.
$353
ALK-Abello, Inc
$302
BioMarin Pharmaceutical Inc.
$298
Octapharma USA, Inc.
$266
Teva Pharmaceuticals USA, Inc.
$213
Novartis Pharmaceuticals Corporation
$191
ADMA BioManufacturing LLC
$160
Blueprint Medicines Corporation
$132
Bio Products Laboratory USA, Inc.
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
kaleo, Inc.
$31
SANOFI-AVENTIS U.S. LLC
$29
Covis Pharma GmBH
$28
HOSPIRA, INC.
$26
Mylan Specialty L.P.
$16
Circassia Pharmaceuticals Inc
$16
Sunovion Pharmaceuticals Inc.
$13
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · BREO · BREZTRI · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · GLASSIA · Gammaplex · Gamunex-C · HYQVIA · Haegarda · Hizentra · Kcentra · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · Odactra · Orladeyo · PANZYGA · PH-Icatibant · PRE-PEN · Prolastin-C Liquid · QVAR · Quzyttir · RUCONEST · SEEBRI · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
504
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lumry is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lumry experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Lumry performed 8,946 allergy immunotherapy preparation services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lumry receive payments from pharmaceutical companies?
Yes. Dr. Lumry received a total of $1,340,333 from 42 companies across 1,617 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lumry's costs compare to other opticians in Dallas?
Dr. Lumry's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lumry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Dallas
Browse opticians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
By company
CSL Behring Payments to Doctors
See all physicians who received payments from CSL Behring.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology